Caplin Point Laboratories Limited
NSE: CAPLIPOINTINE475E01026·HealthcareSmallcap 250·www.caplinpoint.net ↗·Mcap ₹21,217 Cr·Listed 2014
₹2,835.10▼ ₹32.30  (−1.13%)
52W: ₹1,500 – ₹2,990 · Vol: 1.8L shares · Close 25 Sept
Set Alert

Quarterly results

consolidated · as filed with NSE · Q1 FY27 back to Q4 FY18
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q1 FY24Q4 FY23Q3 FY23Q2 FY23Q1 FY23Q4 FY22Q3 FY22Q2 FY22Q1 FY22Q4 FY21Q3 FY21Q2 FY21Q1 FY21Q4 FY20Q3 FY20Q2 FY20Q3 FY19Q2 FY19Q4 FY18
Revenue from operations6106005435345105024934834594534364103953893723593463393263043002792742682.4215228227159156143
Other income33.628.433.730.423.125.731.420.818.617.317.220.41211.414.216.513.911.59.58.59.29.55.81.80.119.610.36.97.772.9
Total expenses4194153733633493523473353233253072852802772742652552512372142202032001901.8170169164107106101
EBITDA21320419018917816816216515214514213712712410910610299.910110192.685.783.987.40.753.867.871.157.855.848.7
EBITDA margin35.0%34.0%34.9%35.4%34.8%33.4%32.9%34.1%33.1%32.0%32.7%33.5%32.0%31.8%29.4%29.4%29.5%29.5%31.0%33.3%30.8%30.7%30.6%32.6%29.8%25.0%29.7%31.3%36.3%35.8%34.0%
Finance costs0.20.40.20.20.20.20.20.20.10.20.20.20.30.20.40.10.10.10.10.20.30.30.30.500.20.10.1000
Depreciation21.618.819.318.416.31716.216.81616.413.911.811.411.111.411.51111.511.711.7129.99.38.90.18.48.47.45.75.66.2
Profit before tax22521320420118417717716915414614514612712411211010599.998.797.789.58580.279.80.764.969.670.559.857.245.4
Tax46.140.63840.833.731.437.237.729.524.825.629.922.822.814.418.418.819.119.420.91817.114.1170.11610.713.31413.710.1
Net profit17917316616015114514013112512112011610410197.49286.380.879.376.871.567.966.162.80.548.958.957.345.843.535.3
Net margin29.3%28.8%30.6%30.0%29.5%28.9%28.4%27.1%27.2%26.7%27.5%28.3%26.4%26.0%26.2%25.6%24.9%23.8%24.3%25.3%23.8%24.4%24.1%23.4%22.7%22.7%25.8%25.2%28.8%27.9%24.6%
EPS (₹)23.2722.3821.5620.3220.1018.7518.2817.2216.3216.0115.4415.1313.6213.4512.8612.0911.2110.439.909.919.378.788.527.527.216.467.747.586.066.214.76
Net profit YoY+18.8%+19.0%+18.4%+22.5%+20.7%+19.8%+16.9%+12.6%+19.9%+19.7%+23.0%+26.2%+20.8%+25.3%+22.8%+19.8%+20.7%+19.0%+19.9%+22.3%+13012.7%+39.0%+12.3%+9.7%––+28.5%+31.7%–––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26FY25FY24FY23FY22FY21FY20FY18
Revenue from operations2,1871,9371,6941,4671,2691,061863540
Other income11696.466.95638.823.541.312.7
Total expenses1,5001,3571,1971,071922771635364
EBITDA761647551441395329260195
EBITDA margin34.8%33.4%32.6%30.1%31.1%31.0%30.1%36.1%
Finance costs0.90.60.80.80.71.60.30.1
Depreciation72.86653.44546.93731.619
Profit before tax803677564451386314269188
Tax15313610374.477.462.254.443.7
Net profit650541461377308251215145
Net margin29.7%27.9%27.2%25.7%24.3%23.7%24.9%26.8%
EPS (₹)84.3670.5760.1949.6239.6132.0328.4219.26
Net profit YoY+20.1%+17.3%+22.4%+22.2%+22.7%+16.9%––
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26FY25FY24FY23FY22
Operating cash flow523432311272337
Investing cash flow−582−335−313−218−271
Financing cash flow−46.5−38.3−38.1−28.2−40.7
Capital expenditure24819214619491.2
Free cash flow (CFO − capex)27524116577.9246

Net profit trend

annual, ₹ crore
FY21
₹251
FY22
₹308+23%
FY23
₹377+22%
FY24
₹461+22%
FY25
₹541+17%
FY26
₹650+20%

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Consolidated12 Aug 2026PDF on NSE XBRL
Q1 FY27Standalone12 Aug 2026PDF on NSE XBRL
Q4 FY26Consolidated · audited14 May 2026PDF on NSE XBRL
Q4 FY26Standalone · audited14 May 2026PDF on NSE XBRL
Q3 FY26Consolidated5 Feb 2026PDF on NSE XBRL
Q3 FY26Standalone5 Feb 2026PDF on NSE XBRL
Q2 FY26Consolidated5 Nov 2025PDF on NSE XBRL
Q2 FY26Standalone5 Nov 2025PDF on NSE XBRL
Q1 FY26Consolidated7 Aug 2025 PDF XBRL
Q1 FY26Standalone7 Aug 2025 PDF XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)5Y avg 19.8×31.8×
P/B5Y avg 4.10×6.01×
ROEFY26, on average equity20.2%
Net margin29.7%
Debt / equity0.00×
Revenue CAGR (3Y)14.2%
Profit CAGR (3Y)19.9%
EPS (TTM)₹89.22
Market cap₹21,547 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
6.01×
vs 8-point avg 4.10× (+47%)
2.41× low4.10× avg6.01× high
History points are balance-sheet dates (2022 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹4,045 Cr+26%
Net worth₹3,586 Cr+26%
Total borrowings₹1 Cr+4%
Cash & bank balances₹94 Cr−53%
Investments₹859 Cr+45%
Inventories₹429 Cr+28%
Trade receivables₹826 Cr+31%
Trade payables₹296 Cr+36%
Change vs the same date a year earlier.
Revenue mix FY26
Rest of the World79.3%result ₹631 Cr
USA20.7%result ₹56.1 Cr
Segment revenue as reported, before inter-segment eliminations.
Shareholding 30 Jun 2026
%Jun 26Mar 26Dec 25Sept 25Jun 25Mar 25Dec 24Sept 24Jun 24Mar 24Dec 23Sept 23
Promoter70.5770.5770.5770.5770.5670.5670.5670.5670.5670.6270.6270.63
FII5.756.156.596.516.175.734.863.703.373.342.853.09
DII2.492.142.052.102.222.012.111.841.491.090.430.20
of which MF2.032.021.971.791.93–––––––
Retail14.6214.4614.1414.2014.3215.1115.7717.1217.5017.5918.3618.31
Other public6.576.686.656.626.736.596.706.787.087.367.747.77
94,385 shareholders · NSE shareholding pattern filings.